Journal of Thyroid Cancer

Vladimir Pushkarev, State Institution V. P. Komisarenko Institute of Endocrinology & Metabolism
National Academy of Medical Sciences of Ukraine
Editorial Board

Vladimir Pushkarev

State Institution V. P. Komisarenko Institute of Endocrinology & Metabolism National Academy of Medical Sciences of Ukraine

Editorial leadership for Journal of Thyroid Cancer ISSN 2574-4496

Research interests

  • Endocrinology
  • &Nbsp;Carcinogenesis
  • Diabetes

Biography

  • State Institution V. P. Komisarenko Institute of Endocrinology & Metabolism,
  • National Academy of Medical Sciences of Ukraine.

Publications:

  1. Thirty Years after the Chernobyl Accident: Molecular Genetic Mechanisms of Carcinogenesis of the Thyroid Gland.
  2. Antineoplastic and apoptotic effects of cannabinoids. N-acylethanolamines: Protectors or killers?
  3. Effects of low and high concentrations of antitumour drug taxol in anaplastic thyroid cancer cells.
  4. Differential effects of low and high doses of Taxol in anaplastic thyroid cancer cells: Possible implication of the Pin1 prolyl isomerase.
  5. Molecular Mechanisms of the Effects of Low Concentrations of Taxol in Anaplastic Thyroid Cancer Cells.
  6. Effects of Paclitaxel and combination of the drug with radiation therapy in an in vivo model of anaplastic thyroid carcinoma.
  7. Expression and activity of extracellular signal-regulated kinase-1/2 (ERK1/2) in normal tissues and human thyroid tumors.
  8. The effect of long-term −80°C storage of thyroid biospecimens on RNA quality and ensuring fitness for purpose.
  9. Involvement of nuclear factor NF-kB in the pathogenesis of type 1 diabetes.
  10. Diabetes and atherosclerosis. Cellular mechanisms of the pathogenesis. Review.

Considering JTC for your work?

This journal is guided by Vladimir Pushkarev (State Institution V. P. Komisarenko Institute of Endocrinology & Metabolism National Academy of Medical Sciences of Ukraine) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.

Start your submission

Menu